{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:41Z","timestamp":1787004821931,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1053\/j.jvca.2017.05.035","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T20:15:48Z","timestamp":1495224948000},"page":"478-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Genetic and Molecular Bases for Hypertrophic Cardiomyopathy: The Role for Calcium Sensitization"],"prefix":"10.1053","volume":"32","author":[{"given":"Xianfeng","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Dong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2017.05.035_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2017.05.035_bib3","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2017.05.035_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"10.1053\/j.jvca.2017.05.035_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2015.01.013","article-title":"The genetic landscape of cardiomyopathy and its role in heart failure","volume":"21","author":"McNally","year":"2015","journal-title":"Cell Metab"},{"key":"10.1053\/j.jvca.2017.05.035_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvv025","article-title":"Genetic advances in sarcomeric cardiomyopathies: State of the art","volume":"105","author":"Ho","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrcardio.2016.98","article-title":"Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy","volume":"13","author":"Ormerod","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1042\/BST20140324","article-title":"The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy","volume":"43","author":"Spudich","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1053\/j.jvca.2017.05.035_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fphys.2014.00392","article-title":"Familial hypertrophic cardiomyopathy: Functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development","volume":"5","author":"Brenner","year":"2014","journal-title":"Front Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI5220","article-title":"Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy","volume":"103","author":"Gao","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2017.05.035_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.yjmcc.2007.03.906","article-title":"Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics","volume":"42","author":"Haim","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.112.270041","article-title":"Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia","volume":"111","author":"Schober","year":"2012","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib14","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: High time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2017.05.035_bib16","first-page":"194","article-title":"Contemporary treatment of hypertrophic cardiomyopathy","volume":"36","author":"Marian","year":"2009","journal-title":"Tex Heart Inst J"},{"key":"10.1053\/j.jvca.2017.05.035_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1213\/ANE.0000000000000538","article-title":"Hypertrophic cardiomyopathy: A review","volume":"120","author":"Hensley","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.05.035_bib18","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1983.245.1.C1","article-title":"Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum [review]","volume":"245","author":"Fabiato","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib19","doi-asserted-by":"crossref","first-page":"23731","DOI":"10.1016\/S0021-9258(17)31576-4","article-title":"NMR studies delineating spatial relationships within the cardiac troponin I-troponin C complex","volume":"269","author":"Krudy","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib20","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1074\/jbc.M212886200","article-title":"Ca2+-induced conformational transition in the inhibitory and regulatory regions of cardiac troponin I","volume":"278","author":"Dong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/372515a0","article-title":"How molecular motors work","volume":"372","author":"Spudich","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2017.05.035_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.8316857","article-title":"Three-dimensional structure of myosin subfragment-1: A molecular motor","volume":"261","author":"Rayment","year":"1993","journal-title":"Science"},{"key":"10.1053\/j.jvca.2017.05.035_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bpj.2014.02.011","article-title":"Hypertrophic and dilated cardiomyopathy: Four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases","volume":"106","author":"Spudich","year":"2014","journal-title":"Biophys J"},{"key":"10.1053\/j.jvca.2017.05.035_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/368306a0","article-title":"Structure of the regulatory domain of scallop myosin at 2.8 A resolution","volume":"368","author":"Xie","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2017.05.035_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00424-013-1433-7","article-title":"Molecular modulation of actomyosin function by cardiac myosin-binding protein C","volume":"466","author":"Previs","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1053\/j.jvca.2017.05.035_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-3495(93)81110-X","article-title":"Regulation of the interaction between actin and myosin subfragment 1: Evidence for three states of the thin filament","volume":"65","author":"McKillop","year":"1993","journal-title":"Biophys J"},{"key":"10.1053\/j.jvca.2017.05.035_bib27","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.05.035_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.yjmcc.2010.03.005","article-title":"Malignant and benign mutations in familial cardiomyopathies: Insights into mutations linked to complex cardiovascular phenotypes","volume":"48","author":"Xu","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000252808","article-title":"Cardiomyopathy: A systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations","volume":"115","author":"Walsh","year":"2010","journal-title":"Cardiology"},{"key":"10.1053\/j.jvca.2017.05.035_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198903233201209","article-title":"Hypertrophic cardiomyopathy\u2014continued progress","volume":"320","author":"Braunwald","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","article-title":"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy","volume":"326","author":"Watkins","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCRESAHA.110.223842","article-title":"Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor","volume":"111","author":"Moore","year":"2012","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1295-434","article-title":"Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy","volume":"11","author":"Watkins","year":"1995","journal-title":"Nat Genet"},{"key":"10.1053\/j.jvca.2017.05.035_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","article-title":"In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament","volume":"108","author":"Harris","year":"2011","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10974-011-9268-3","article-title":"How do MYBPC3 mutations cause hypertrophic cardiomyopathy?","volume":"33","author":"Marston","year":"2012","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1053\/j.jvca.2017.05.035_bib36","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.yjmcc.2009.10.031","article-title":"Mutations in troponin that cause HCM, DCM AND RCM: What can we learn about thin filament function?","volume":"48","author":"Willott","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cjca.2015.06.015","article-title":"A systematic review of phenotypic features associated with cardiac troponin I mutations in hereditary cardiomyopathies","volume":"31","author":"Mogensen","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCGENETICS.111.959973","article-title":"Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene","volume":"5","author":"Pasquale","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1053\/j.jvca.2017.05.035_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2008.05.003","article-title":"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C","volume":"45","author":"Landstrom","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fphys.2016.00429","article-title":"Cardiac troponin and tropomyosin: Structural and cellular perspectives to unveil the hypertrophic cardiomyopathy phenotype","volume":"7","author":"Marques","year":"2016","journal-title":"Front Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(94)90054-X","article-title":"Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere","volume":"77","author":"Thierfelder","year":"1994","journal-title":"Cell"},{"key":"10.1053\/j.jvca.2017.05.035_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10974-013-9358-5","article-title":"Alpha-tropomyosin mutations in inherited cardiomyopathies","volume":"34","author":"Redwood","year":"2013","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1053\/j.jvca.2017.05.035_bib43","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1074\/jbc.M114.596676","article-title":"Mechanistic heterogeneity in contractile properties of alpha-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies","volume":"290","author":"Gupte","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10974-015-9423-3","article-title":"Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations","volume":"36","author":"Huang","year":"2015","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1053\/j.jvca.2017.05.035_bib45","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1136\/jmg.2003.010447","article-title":"Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy","volume":"41","author":"Mogensen","year":"2004","journal-title":"J Med Genet"},{"key":"10.1053\/j.jvca.2017.05.035_bib46","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1742-4658.2005.04630.x","article-title":"Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation","volume":"272","author":"Vang","year":"2005","journal-title":"FEBS J"},{"key":"10.1053\/j.jvca.2017.05.035_bib47","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12265-009-9128-3","article-title":"Hypertrophic cardiomyopathy: The early years","volume":"2","author":"Braunwald","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.CIR.35.5.847","article-title":"Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade","volume":"35","author":"Cohen","year":"1967","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.05.035_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1050-1738(02)00181-0","article-title":"Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy","volume":"12","author":"Lowey","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.272.5262.731","article-title":"A mouse model of familial hypertrophic cardiomyopathy","volume":"272","author":"Geisterfer-Lowrance","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.jvca.2017.05.035_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12265-011-9266-2","article-title":"How do mutations in contractile proteins cause the primary familial cardiomyopathies?","volume":"4","author":"Marston","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib53","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00128.2007","article-title":"Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay","volume":"293","author":"Debold","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib54","doi-asserted-by":"crossref","first-page":"H1939","DOI":"10.1152\/ajpheart.00644.2007","article-title":"Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex","volume":"294","author":"Palmer","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1023\/A:1005678905119","article-title":"R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level","volume":"21","author":"Palmiter","year":"2000","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1053\/j.jvca.2017.05.035_bib56","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1113\/jphysiol.2008.155952","article-title":"The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils","volume":"586","author":"Belus","year":"2008","journal-title":"J Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib57","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1113\/jphysiol.2014.274571","article-title":"Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation","volume":"592","author":"Witjas-Paalberends","year":"2014","journal-title":"J Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib58","doi-asserted-by":"crossref","first-page":"H1097","DOI":"10.1152\/ajpheart.00650.2004","article-title":"Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations","volume":"288","author":"Alpert","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib59","doi-asserted-by":"crossref","first-page":"12607","DOI":"10.1073\/pnas.1309493110","article-title":"Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human beta-cardiac myosin motor function","volume":"110","author":"Sommese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jvca.2017.05.035_bib60","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.celrep.2015.04.006","article-title":"Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector","volume":"11","author":"Aksel","year":"2015","journal-title":"Cell Rep"},{"key":"10.1053\/j.jvca.2017.05.035_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jeb.125930","article-title":"Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human beta-cardiac myosin","volume":"219","author":"Spudich","year":"2016","journal-title":"J Exp Biol"},{"key":"10.1053\/j.jvca.2017.05.035_bib62","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: Haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.05.035_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2015.12.014","article-title":"The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position","volume":"91","author":"Mun","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib64","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1006\/jmcc.2001.1473","article-title":"Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy","volume":"33","author":"Takahashi-Yanaga","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib65","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1074\/jbc.275.1.624","article-title":"Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy","volume":"275","author":"Szczesna","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib66","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCRESAHA.107.156380","article-title":"Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments","volume":"101","author":"Robinson","year":"2007","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib67","doi-asserted-by":"crossref","first-page":"41742","DOI":"10.1074\/jbc.M303408200","article-title":"Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility","volume":"278","author":"Heller","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib68","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/70990","article-title":"Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes","volume":"5","author":"Michele","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.RES.0000027530.58419.82","article-title":"Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade","volume":"91","author":"Michele","year":"2002","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jmb.2006.06.018","article-title":"Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations","volume":"361","author":"Wang","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1053\/j.jvca.2017.05.035_bib71","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1096\/fj.08-118182","article-title":"Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice","volume":"23","author":"Kerrick","year":"2009","journal-title":"FASEB J"},{"key":"10.1053\/j.jvca.2017.05.035_bib72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmcc.2002.2025","article-title":"Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy","volume":"34","author":"James","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib73","doi-asserted-by":"crossref","first-page":"20579","DOI":"10.1074\/jbc.M800554200","article-title":"Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone","volume":"283","author":"Lowey","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib74","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1172\/JCI3880","article-title":"A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy","volume":"102","author":"Yang","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2017.05.035_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature01780","article-title":"Structure of the core domain of human cardiac troponin in the Ca2+-saturated form","volume":"424","author":"Takeda","year":"2003","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2017.05.035_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10974-014-9382-0","article-title":"Biochemical characterization of troponin C mutations causing hypertrophic and dilated cardiomyopathies","volume":"35","author":"Kalyva","year":"2014","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1053\/j.jvca.2017.05.035_bib78","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/S0006-3495(01)75924-3","article-title":"Disease-causing mutations in cardiac troponin T: Identification of a critical tropomyosin-binding region","volume":"81","author":"Palm","year":"2001","journal-title":"Biophys J"},{"key":"10.1053\/j.jvca.2017.05.035_bib79","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1073\/pnas.0509181102","article-title":"Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice","volume":"102","author":"Ertz-Berger","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jvca.2017.05.035_bib80","doi-asserted-by":"crossref","first-page":"27749","DOI":"10.1074\/jbc.M115.683045","article-title":"Troponin I mutations R146G and R21C alter cardiac troponin function, contractile properties, and modulation by protein kinase A (PKA)-mediated phosphorylation","volume":"290","author":"Cheng","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2017.05.035_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCRESAHA.111.242974","article-title":"Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy","volume":"109","author":"Ashrafian","year":"2011","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2014.02.022","article-title":"Advances in medical treatment of hypertrophic cardiomyopathy","volume":"64","author":"Hamada","year":"2014","journal-title":"J Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cvr\/cvv023","article-title":"Targets for therapy in sarcomeric cardiomyopathies","volume":"105","author":"Tardiff","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib84","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"key":"10.1053\/j.jvca.2017.05.035_bib85","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1053\/j.jvca.2017.05.035_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJM200002103420609","article-title":"Sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Watkins","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.05.035_bib87","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.13194","article-title":"Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: Triggers, treatment and implications","volume":"28","author":"Link","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib88","first-page":"3893","article-title":"Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice","volume":"118","author":"Baudenbacher","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2017.05.035_bib89","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000262655.16373.37","article-title":"Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction","volume":"100","author":"de Waard","year":"2007","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2017.05.035_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrtlng.2015.02.003","article-title":"Impacts of cardiac rehabilitation on ventricular repolarization indexes and ventricular arrhythmias in patients affected by coronary artery disease and type 2 diabetes","volume":"44","author":"Boukhris","year":"2015","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2017.05.035_bib91","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.amjcard.2006.07.043","article-title":"Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy","volume":"98","author":"Flevari","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2017.05.035_bib92","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13019-016-0556-2","article-title":"Impact of prophylactic administration of levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery \u2013 a retrospective analysis","volume":"11","author":"Grieshaber","year":"2016","journal-title":"J Cardiothorac Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701730513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701730513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:18:03Z","timestamp":1692796683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307701730513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S105307701730513X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2017.05.035","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Genetic and Molecular Bases for Hypertrophic Cardiomyopathy: The Role for Calcium Sensitization","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2017.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}